![]() ![]() Judas Priest’s Rob Halford – PCAM Edition Prostate Cancer Uncensored: Hosted by Jay Jay French | Feat.Prostate Cancer Uncensored: Black Men’s Prostate Cancer Initiative & Support Groups – Guests: Hakim Asadi & Marcus Jones.Prostate Cancer Uncensored Podcast | Feat. ![]() Coronavirus (COVID-19) and Prostate Cancer.Exercise, Physical Activity, and Prostate Cancer.Informed Consent and Patient Protection.Download a FREE Newly Diagnosed Patient Guide.Black/African Americans and Prostate Cancer.Other Prostate Conditions (Related & Unrelated).While none of these tests are conclusive on their own, when performed in addition to a PSA test, DRE, and a biopsy, they can provide each patient with more information about their specific cancer and can aid in both the diagnosis and decision on treatment. There are additional tests that can give your doctor more information on how to determine the probability of both finding cancer during a biopsy and determining how aggressive that cancer is likely to be. Visit our advocacy site to learn about ZERO’s advocacy efforts in early detection and access to PSA screening.Ī biopsy will be needed to confirm whether prostate cancer is present or not. A PSA test score is an important part of making a decision on how best to determine a prostate cancer diagnosis and/or treatment pathway. Researchers, with support from organizations like ZERO, are working every day to improve prostate cancer screening, but for now, we must use the tools we have. The National Comprehensive Cancer Network® (NCCN) and ZERO strongly recommend that men should be fully educated about prostate cancer, should know their options for early detection, and should have access to the tests we have available now. Like the 2012 recommendation, this update does not include specific language for men at increased risk. This means that the USPSTF recognizes a small potential benefit of PSA testing and recommends that men make individual decisions about whether or not to get tested after discussing the risks and benefits with their doctors. This was in response to research demonstrating the benefits of PSA screening (such as the European Randomized Study of Screening for Prostate Cancer ), an increase in the number of men choosing active surveillance, and advocacy efforts. In 2018, the USPSTF updated their recommendation on PSA screening, assigning the PSA test a “C” rating for men ages 55 to 69 (the test still has a “D” rating for men ages 70+). Prior to its “D” rating, the PSA test had an “I” rating, meaning the USPSTF concluded there was insufficient evidence to assess the pros and cons of testing. The USPSTF recommendation is important as it guides primary care physicians in preventive care and can impact insurance coverage and reimbursement for screening. This recommendation did not include exceptions for men at increased risk of developing the disease, such as Black or African American men, those with a family history of the disease, and those with BRCA gene mutations. ![]() This meant that the USPSTF concluded the harms that resulted from PSA testing, such as unnecessary biopsies and negative treatment side effects, outweighed the benefits of finding and managing the disease early. ![]() Preventive Services Task Force (USPSTF) assigned the PSA test a “D” rating. The latest NCCN recommendations are covered above in the Prostate Cancer Early Detection: Age Recommendations and PSA Levels Chart. If PSA greater than 4 ng/mL or a very suspicious DRE, talk with your doctor about further testing and follow-up.If PSA less than 4 ng/mL and DRE normal (if done), repeat testing in select patients every 1 – 4 years.Talk with your doctor about if prostate cancer screening should continue.Have a baseline PSA and strongly consider a baseline DRE.If PSA 1 – 3 ng/mL and DRE normal (if done), repeat testing every 1 – 2 years.If PSA less than 1 ng/mL and DRE normal (if done), repeat testing every 2 – 4 years.Have a baseline PSA and strongly consider a baseline digital rectal exam (DRE).Discuss the risk and benefits of prostate cancer screening with your doctor.Have a family history of cancer and/or a known genetic mutation that increases the risk for prostate cancer.The below table also provides guidance on what is considered a normal PSA range, and what may be considered a dangerous PSA level. Please use these guidelines to have a discussion with your doctor about your personal risk and make a plan for screening. The age recommendations and guidance in the below PSA levels chart are adapted from the National Comprehensive Cancer Network Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Prostate Cancer Early Detection. The LGBTQIA+ Community and Prostate Cancer. ![]()
0 Comments
Leave a Reply. |